Programme

Overview: This symposium explores the role of quantitative MRI biomarkers in radiation therapy (RT) response assessment, with a focus on their validation for multicenter clinical trials. Experts will discuss the integration of biological image-guided adaptive RT, standardization of MRI sequences, and robust parameter extraction across institutions. The session will also highlight the potential of deep learning in MRI parameter estimation and the role of hypoxia imaging in clinical trials. A panel discussion will address challenges and opportunities in advancing MRI biomarkers for precision RT.

Overview: This session will focus on enhancing the expertise of radiation therapists in reirradiation workflows, addressing challenges in treatment planning, and exploring how evolving practices are reshaping their roles. Topics will include innovative approaches to reirradiation processes, effective strategies for overcoming planning obstacles, and the broader implications of reirradiation on the practice of radiation therapists. This symposium highlights the vital contributions of radiation therapists to improving patient care in radiation oncology.

Overview: The optimal indication and implementation of brachytherapy as a boost after external radiotherapy for locally advanced prostate cancer is often a subject of controversy. The aim of the symposium is to present and discuss the current issues about the indication of brachytherapy as a boost from different perspectives - from the point of view of medical physics, radiation biology and radiation oncologists, in particular the current quality of evidence of brachytherapy as a boost with regard to efficacy and side effects. In addition, the current evidence for patient selection and the possible use of artificial intelligence in prostate brachytherapy will be presented.

Overview: The joint ESTRO-EADO symposium is aimed at highlighting the importance of close cooperation between dermato-oncologist, surgeons, radiation / clinical oncologists, onco-geriatricians and allied health care professionals such as medical physicists, radiographers and nurses. Such cooperation would not be possible without continued mutual understanding of advancements in each speciality, allowing to work together towards a common goal. This year’s theme of the joint ESTRO-EADO symposium is “Behind local control: Modern integrated opportunities in the management of non-melanoma skin cancer”. The first talk will cover quality of life studies in non-melanoma skin cancer and personalized integrated care. The next session will give an overview of Mohs surgery, a microscopically margin controlled procedure to treat skin cancer that revolutionised skin surgery. Following that the decision-making experiment will be discussed as an alternative approach to harmonise clinical practice in the areas of skin cancer management where recommendations are not uniform. Finally, we will hear from medical physicist describing their work behind the scene in skin radiotherapy and from radiographer how they support patient journey during and after skin radiotherapy.